Skip to main content

The Oncology Pharmacist® features articles written by and for oncology pharmacists and specifically addresses the issues pharmacists and their colleagues face every day in clinical practice.

Featured Articles

Clinical Trials

US-Based Clinical Trials That Are Actively Recruiting in Cervical Cancer

Clinical trial recruitment and retention remain challenges in the quest to bring innovative therapies to all patients in need. In oncology, therapies continue to evolve, yet researchers are frequently faced with low trial participation, particularly among minority groups.
Continue Reading
Managing Your Wealth

How to View Your Investments in 2025

As an investor, it can be difficult to navigate the ups and downs of the market and understand what the movements mean for your portfolio— particularly when you’re seeing constant headlines on the topic.
Continue Reading
Perspective,Clinical Trials

North American Enrollment in Clinical Trials: An Emerging Issue for Regulatory Approval

On May 20, 2025, the FDA had a meeting of its Oncologic Drug Advisory Committee (ODAC).
Continue Reading

Top Trending Articles

North American Enrollment in Clinical Trials: An Emerging Issue for Regulatory Approval
A Decade of Magical Reflections: Creating Value and Offering Hope in Oncology
US-Based Clinical Trials That Are Actively Recruiting in Cervical Cancer

In the Literature

Consumption of Ultra-Processed Foods Linked to Higher Cancer Risk
RIT Researcher Develops Math Models to Help Predict Patients’ Medication Adherence
Provider and Patient Education Critical for Improving Biosimilar Adoption

Healthcare Disparities

Implementing an Oral Cancer Drug Repository Service: Cowell Family Cancer Center
Study Shows Health Insurance Status Mediates Racial and Ethnic Inequities in Advanced-Stage Cervical Cancer
Addressing Health Equity in Bladder Cancer Care

Practical Issues for Pharmacists

Prior Authorization Payer Changes, Hope or Hype?
Biosimilar Utilization Management Within an Employee Health Plan Population
Implementing an Oral Cancer Drug Repository Service: Cowell Family Cancer Center

Featured Video

Longer-Term Follow-Up of Amivantamab + Lazertinib vs Osimertinib From the MARIPOSA Study

In the final video of this Rapid Reactions series, Beth Sandy, MSN, CRNP, FAPO, discusses data that continue to favor first-line amivantamab plus lazertinib over osimertinib in patients with EGFR-mutant advanced non-small cell lung cancer after a median of 31 months of follow-up.

View Video
View Video Series

OCTOBER SPOTLIGHT

October Is Breast Cancer Awareness Month

October is Breast Cancer Awareness Month. The purpose of this national campaign–– which encompasses a wide range of initiatives conducted by local community organizations, breast cancer advocacy organizations, and major retailers–– is to educate the public about breast cancer risk factors, promote screening and prevention, support individuals diagnosed with the disease and their loved ones, and raise funds for breast cancer research. Breast Cancer Awareness Month has been on the national calendar since 1985.

View Breast Cancer Articles

FDA Updates

FDA Granted Second Approval for Epkinly to Treat Patients With Relapsed or Refractory Follicular Lymphoma
FDA News: September 11, 2023, to October 16, 2023
FDA News: August 9, 2023, to August 14, 2023

Value-Based Care
 

Biosimilars in Oncology Can Reduce Healthcare Costs
Survey Shows Inflation Affecting Majority of Consumer Healthcare Decisions
Study Confirms Cost Savings Associated with Telehealth Use in Cancer Care